Division of Clinical Immunology and Allergy, McMaster University, Hamilton, Ontario, Canada.
J Allergy Clin Immunol. 2011 Feb;127(2):447-53. doi: 10.1016/j.jaci.2010.11.006. Epub 2010 Dec 16.
Little is known regarding the prenatal determinants of innate immune responses in relation to infant allergic risk. Environmental exposures, including microbial stimuli, might predispose susceptible subjects to atopy and asthma in early infancy or even in utero.
Because Toll-like receptors (TLRs) recognize microbial products and because cord blood (CB) progenitor alterations have been observed in neonates at risk for atopy, we investigated the expression and function of TLRs on CB hematopoietic progenitors in relation to atopic risk, as defined by maternal allergic sensitization.
Thirty-two (15 with low and 17 with high atopic risk) infant CB samples were assessed for phenotypic and functional alterations in CD34(+) cells by means of flow cytometry and methylcellulose culture, respectively. CD34(+) hematopoietic progenitors were stained for TLR-2, TLR-4, TLR-9, GM-CSF receptor α, IL-5 receptor α, and IL-3 receptor α or cultured in methylcellulose assays for hematopoietic cytokine-stimulated eosinophil-basophil (Eo/B) colony-forming units (CFUs) with or without LPS.
High-atopic-risk infants had significantly lower CB CD34(+) cell TLR-2, TLR-4, and TLR-9 expression (P = .009). High-risk infant progenitors gave rise to significantly more Eo/B CFUs (P = .002) with hematopoietic cytokine (IL-3, IL-5, or GM-CSF) stimulation ex vivo. Although LPS costimulation induced Eo/B CFUs from both low- and high-risk infant CB CD34(+) cells, this response was significantly (P = .020) muted in the high-risk CB progenitors.
Neonatal CB CD34(+) hematopoietic progenitor cell TLR expression and functional responsiveness are altered in CB from atopic at-risk infants. Maternal allergic sensitization might modulate hematopoietic progenitor TLR expression and function in utero; specifically, Eo/B "lineage priming" at birth might be circumvented through engagement of TLR pathways in early life.
关于与婴儿过敏风险相关的先天免疫反应的产前决定因素,我们知之甚少。环境暴露,包括微生物刺激,可能使易感个体在婴儿早期甚至在子宫内就容易患上特应症和哮喘。
由于 Toll 样受体 (TLR) 识别微生物产物,并且已经观察到处于特应性风险中的新生儿的脐带血 (CB) 祖细胞发生改变,因此我们研究了 CB 造血祖细胞上 TLR 的表达和功能与特应性风险的关系,特应性风险由母体过敏致敏来定义。
通过流式细胞术和甲基纤维素培养,分别评估了 32 个(15 个低特应性风险和 17 个高特应性风险)婴儿 CB 样本中 CD34+细胞的表型和功能改变。用 TLR-2、TLR-4、TLR-9、GM-CSF 受体α、IL-5 受体α 和 IL-3 受体α 对 CD34+造血祖细胞进行染色,或在含有或不含 LPS 的甲基纤维素测定中培养,用于造血细胞因子刺激的嗜酸性粒细胞-嗜碱性粒细胞(Eo/B)集落形成单位(CFU)。
高特应性风险婴儿的 CB CD34+细胞 TLR-2、TLR-4 和 TLR-9 表达明显降低(P =.009)。高风险婴儿的祖细胞在体外用造血细胞因子(IL-3、IL-5 或 GM-CSF)刺激时,产生的 Eo/B CFU 明显更多(P =.002)。尽管 LPS 共刺激诱导了来自低和高风险婴儿 CB CD34+细胞的 Eo/B CFU,但这种反应在高风险 CB 祖细胞中明显受到抑制(P =.020)。
特应性高危婴儿的 CB CD34+造血祖细胞 TLR 表达和功能反应性发生改变。母体过敏致敏可能在子宫内调节造血祖细胞 TLR 的表达和功能;具体而言,出生时 Eo/B“谱系启动”可能通过在生命早期参与 TLR 途径来避免。